Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Open Studies | "Candidiasis, Oral"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis
Condition: Vulvovaginal Candidiasis
Interventions: Biological: NDV-3A;   Biological: NDV-3;   Biological: Placebo

Indicates status has not been verified in more than two years